Starting 31 July 2026, a new 100% tariff on patented pharmaceuticals triggered by Section 232 national security powers is set to reshape drug supply chains and import strategies across the U.S. Key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results